Long-term ALS survival benefit with CNM-Au8 seen in trial analyses

Cells, Free Full-Text

Trial Results from Clene Nanomedicine Strike ALS Research

Articles about Clene Nanomedicine, Inc

Results of Clinical Trials for CNM-Au8, A Potential ALS Treatment: James Berry, MD, MPH

Clene Nanomedicine, Inc. on LinkedIn: #als #cnmau8 #gold #nanocrystal #neurodegeneration

Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension - eClinicalMedicine

Cells, Free Full-Text

CNM-Au8 Found to Lower Risk of Death in ALS in HEALEY Platform Trial, Clene Therapy Fails to Meet Trial Goals or Slow Functional Decline

A Mechanism Underpinning the Bioenergetic Metabolism‐Regulating Function of Gold Nanocatalysts - Wang - Small - Wiley Online Library

Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension - eClinicalMedicine

MDA2022 – CNM-Au8 May Slow ALS Progression, Reduce Mortality Risk